Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
The Long Run with Luke Timmerman
00:00
Cancer
When you go to genate, and i think this was mid nineties, 95. Em geneta had three approved drugs, growth harmon activas and palmasime. They wanted, they had aspirations to be a cancer company. Art levinson was ahead of our end. It was pretty a wild west compared to the buttoned upit was myre squab. So it's really different.
Transcript
Play full episode
